Recursion Pharmaceuticals, Inc.

ExodusPoint Capital Management, LP RXRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

391,801

Value ($000)

1,602

Weight

0.0%

2022 Q1 - 2025 Q4 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,602	0.0%	391,801	12/31/2025
2025 Q2	8/13/2025	230	0.0%	45,413	6/30/2025
2024 Q1	5/14/2024	615	0.0%	61,689	3/31/2024
2023 Q1	5/11/2023	208	0.0%	31,137	3/31/2023
2022 Q3	11/10/2022	488	0.0%	45,832	9/30/2022
2022 Q2	8/22/2022	1,563	0.0%	192,073	6/30/2022
2022 Q1	5/13/2022	241	0.0%	33,713	3/31/2022